Private Content: That content is private. You can get access by registering for an affiliated class or event, or by messaging the content creator directly.
Caldwell B. Esselstyn, Jr., received his B.A. from Yale University and his M.D. from Western Reserve University. In 1956, pulling the No. 6 oar as a member of the victorious United States rowing team, he was awarded a gold medal at the Olympic Games. He was trained as a surgeon at the Cleveland Clinic and at St. George’s Hospital in London. In 1968, as an Army surgeon in Vietnam, he was awarded the Bronze Star. His scientific publications number over 150, “The Best Doctors in America” 1994-1995 published by Woodward and White cites Dr. Esselstyn’s surgical expertise in ...See All
Member of the 1956 United States Olympic Team, awarded Gold Medal in 8-Oared Rowing Event President - Nu Sigma Nu Medical Fraternity, 1960 . Bronze Star, Vietnam Campaign, May 1968 President - Cleveland Surgical Society, 1983 President - Medical Staff Cleveland Clinic Foundation, 1977-78 Member of the Board of Trustees, Cleveland Clinic Foundation, 1981-1983 Member of Board of Governors, Cleveland Clinic Foundation, 1979-1984 President - Rupert Turnbull Society, 1982-1983 President - Cleveland Clinic Surgical Society, 1984 Member of the Board of Trustees of the Medical Alumni Association of Case Western Reserve ...See All
A groundbreaking program backed by the irrefutable results from Dr. Esselstyns 20-year study proving changes in diet and nutrition can actually cure heart disease. Dr. Esselstyn featured in the recent documentary Forks Over Knives, will present live. Register now to secure your spot in this interactive session.
The proof is in the results. The patients in Dr. Esselstyns initial study came to him with advanced coronary artery disease. Despite the aggressive treatment they received, among them bypasses and angioplasties, 5 of the original group were told by their cardiologists they had less than a year to live. Within months on Dr. Esselstyns program, their cholesterol levels, angina symptoms, and blood flow improved dramatically. Twelve years later 17 compliant patients had no further cardiac events. Adherent patients survived beyond twenty years free of symptoms.